Brief treatment for anxiety and PTSD in South Africa

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates a brief transdiagnostic treatment for anxiety disorders and post-traumatic stress disorder (PTSD) in South Africa, delivered by non-specialist providers in primary care clinics. The intervention, known as False Safety Behavior Elimination Treatment (F-SET), aims to address the high prevalence of these conditions in low and middle-income countries where access to evidence-based treatments is limited. Participants receiving the brief intervention will be compared to those receiving enhanced standard care, allowing for an assessment of both effectiveness and implementation barriers. The study seeks to provide a culturally congruent and less complex treatment option for individuals in need.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Participants diagnosed with a primary anxiety disorder (panic disorder, generalized anxiety disorder, social anxiety disorder, or obsessive-compulsive disorder) or post-traumatic stress disorder.

Exclusion Criteria:

* Participants who are acutely suicidal, have severe alcohol of substance use disorder, or are engaged in another form of psychotherapy.

Where it's running

• Stellenbosch University
  Cape Town, South Africa Recruiting

Study contacts

• Study coordinator: Kristina Korte, PhD
• Email: kkorte@mgh.harvard.edu
• Phone: 6177268205

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Cognitive training for anxiety, depression, and PTSD

  This study is testing a brain training program to see if it can help people with anxiety, depression, or PTSD think more clearly and feel better.

  Recruiting Phase 2/3 University of California, San Diego · San Diego, California · NCT06273527

• Home use of ketamine for chronic conditions

  This study is testing whether taking ketamine at home can help people with chronic pain, depression, or PTSD feel better and improve their symptoms.

  Recruiting at 2 sites RIVER Foundation · Bigfork, Montana and 1 other locations · NCT06070766

• Understanding anxiety, depression, and bipolar disorder over time in China

  This study tests how anxiety, depressive, and bipolar symptoms change over three years to find patterns that help with earlier recognition and prediction in people aged 12–55.

  Recruiting Second Affiliated Hospital, Zhejiang University, School of Medicine · Hangzhou, Zhejiang · NCT07903246

• Anger, Social Thinking, and PTSD in French Veterans

  This study tests whether PTSD in former French military personnel is linked to higher anger through changes in social thinking abilities.

  Recruiting Direction Centrale du Service de Santé des Armées · Draguignan · NCT07851090

• TSND-201 treatment for PTSD in adults

  This study tests two doses of TSND-201 or placebo to see if it helps adults with PTSD.

  Recruiting at 9 sites Phase 3 Transcend Therapeutics · Denver, Colorado and 8 other locations · NCT07836647

• See if personalized CBM-I can help anxious kids ages 10–17

  Aimed at youth with Generalized, Separation, or Social Anxiety, the study tests a personalized cognitive bias modification for interpretation (CBM-I) to see if it reduces threat-focused thinking and anxiety.

  Recruiting University of Denver · Denver, Colorado · NCT07818876

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.